The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety of combining radiotherapy and antibody drug conjugates in advanced urothelial and other cancers.
 
Derrick Lock
No Relationships to Disclose
 
Yash Soni
No Relationships to Disclose
 
Lindsay Hwang
No Relationships to Disclose
 
Suzanne Cole
Research Funding - Exelixis (Inst); Merck (Inst); QED Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; Clovis Oncology; Dendreon; Foundation Medicine; Gilead Sciences; Janssen Scientific Affairs; Myovant Sciences; Procept Biorobotics; Progenics; Seagen
 
Anishka D'souza
No Relationships to Disclose
 
Aurelie Garant
Honoraria - Intellisphere
Consulting or Advisory Role - Intellisphere
Research Funding - FDA; Teleflex Medical
 
Daniel Yang
No Relationships to Disclose
 
Waddah Arafat
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); Merck (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
 
Tian Zhang
Leadership - Archimmune Therapeutics (I); Capio BioSciences (I)
Stock and Other Ownership Interests - Archimmune Therapeutics (I); Capio Biosciences (I); Nanorobotics (I)
Honoraria - Aptitude Health; Clinical Care Options; Curio Science; Mashup Media; MJH Life Sciences; Peerview
Consulting or Advisory Role - Aravive; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Gilead Sciences; Janssen; Lilly; Loxo/Lilly; Merck; Novartis; Pfizer; Sanofi/Aventis; Seagen; Xencor
Research Funding - ALX Oncology (Inst); Astellas Pharma (Inst); Bayer (Inst); Exelixis (Inst); Janssen (Inst); Janux Therapeutics (Inst); Loxo/Lilly (Inst); OncoC4; Pfizer (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture by c-MET technology (Inst); Prochelators as Targeted Prodrugs for Prostate Cancer (Inst)
Travel, Accommodations, Expenses - Bayer
Other Relationship - ASCO; Kidney Cancer Association; KidneyCan; Myrovlytis Trust; Winn Foundation
 
Leslie Ballas
Employment - Cedars-Sinai
Honoraria - UpToDate
Consulting or Advisory Role - Blue Earth Diagnostics; Johnson and Johnson; Pfizer/Astellas; UroToday
Research Funding - Astellas Pharma
 
Neil Desai
Consulting or Advisory Role - Boston Scientific; Novartis; Telix Pharmaceuticals
Speakers' Bureau - Ultimate Medical Academy
Research Funding - Boston Scientific (Inst); Reflexion Medical (Inst); Reflexion Medical (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer
(OPTIONAL) Uncompensated Relationships - Bayer